ARREX
Price
$26.47
Change
+$0.02 (+0.08%)
Updated
Jun 4 closing price
Net Assets
593.67M
VRTPX
Price
$21.52
Change
+$0.06 (+0.28%)
Updated
Jun 4 closing price
Net Assets
9.42B
Interact to see
Advertisement

ARREX vs VRTPX

Header iconARREX vs VRTPX Comparison
Open Charts ARREX vs VRTPXBanner chart's image
American Century Real Estate R5
Price$26.47
Change+$0.02 (+0.08%)
VolumeN/A
Net Assets593.67M
Vanguard Real Estate II Index
Price$21.52
Change+$0.06 (+0.28%)
VolumeN/A
Net Assets9.42B
ARREX vs VRTPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ARREX vs. VRTPX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARREX is a Buy and VRTPX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VRTPX has more cash in the bank: 9.42B vs. ARREX (594M). VRTPX pays higher dividends than ARREX: VRTPX (3.97) vs ARREX (2.11). ARREX was incepted earlier than VRTPX: ARREX (8 years) vs VRTPX (8 years). ARREX (0.95) is less costly to investors than VRTPX (0.08). ARREX is a more actively managed with annual turnover of: 96.00 vs. VRTPX (4.00). ARREX has a lower initial minimum investment than VRTPX: ARREX (0) vs VRTPX (100000000). ARREX annual gain was more profitable for investors over the last year : 12.19 vs. VRTPX (11.12). VRTPX return over 5 years is better than : 27.11 vs. ARREX (9.59).
ARREXVRTPXARREX / VRTPX
Total Expense Ratio0.950.081,188%
Annual Report Gross Expense Ratio0.950.081,188%
Fund Existence8 years8 years-
Gain YTD0.6541.16556%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets594M9.42B6%
Annual Yield % from dividends2.113.9753%
Returns for 1 year12.1911.12110%
Returns for 3 years-3.112.30-135%
Returns for 5 years9.5927.1135%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RERBX57.210.39
+0.69%
American Funds EUPAC R2
MLPZX6.560.04
+0.58%
Invesco SteelPath MLP Income Y
CVFYX15.30N/A
N/A
Pioneer Disciplined Value Y
ETIHX32.71N/A
N/A
Eventide Healthcare & Life Sciences I
PZVNX11.76N/A
N/A
Pzena International Value Investor